AUG 13, 2018 06:49 AM PDT

In a First, Stem Cell Therapy for Parkinson's in Human Patients

WRITTEN BY: Carmen Leitch

A clinical trial that is the first of its kind has been started in Japan. In an effort to treat Parkinson’s disease, scientists will first use banked materials to create induced pluripotent stem (iPS) cells, which will then generate dopaminergic progenitors. Those will be put into the brains of patients where they will grow into neurons that make dopamine, to try to reduce the neural degeneration that is a hallmark of Parkinson’s disease.

It’s been established that the disease happens when nerves in the brain that produce dopamine, a neurotransmitter, die off. That disrupts motor function and makes it hard for affected individuals to walk; they also experience tremors. Dementia sets in later.

Announced in July, scientists at Kyoto University's Center for iPS Cell Research and Application (CiRA) and Kyoto University Hospital aimed to recruit seven patients, who would be tracked for two years after their procedure was completed.

To make iPS cells, which act as a kind of generic cell that is capable of specializing to become any type of cell in the body, a Nobel-prize winning technique is applied to reprogram those cells. By manipulating the expression of a few genes, skin cells turn into iPS cells. 

This trial will be slightly different from some others in that it will use donated cellular material rather than stuff taken from the patient. The researchers expect that the match will still be close enough, and there will not be an adverse reaction.

After the iPS cells are used to create dopaminergic progenitors, they get injected into the putamen, at the base of the forebrain. Two small holes have to be drilled into the patient’s skull. The scientists will then inject around five million of the engineered cells.

Human embryonic stem cells/ Credit: Nissim Benvenisty

It will be faster and more cost effective to generate the cells they need from stocks, Science reported in 2017. It could open up new therapeutic options for a far greater number of people as well. Instead of having to wait to treat cells removed from a patient, banked cells could be applied almost immediately.

To that end, Shinya Yamanaka, who pioneered the iPS technique and won the Nobel, is creating an iPS bank. Donors and recipients can be matched by checking three genes that help encode for an important molecule in the immune system, the human leukocyte antigens (HLAs), which sit on the outside of cells and trigger an immune response.

Researchers remain cautious but hopeful that many diseases might be treatable with stem cell techniques.

Sources: Science, Nature

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 18, 2019
Neuroscience
OCT 18, 2019
Scientists discover new pain-sensing organ in skin
Schwann cells are octopus-like cells in the nervous system that wrap around nerve cells, jelly-roll fashion, to form a special insulating layer. These cell...
OCT 18, 2019
Microbiology
OCT 18, 2019
Unlocking the Secret of Carbapenem Resistance in a Hospital Pathogen
While attention has been brought to the issue and some progress has been made, hospital-acquired infections are still a major problem....
OCT 18, 2019
Cell & Molecular Biology
OCT 18, 2019
Using CRISPR to Track and Image Genome Editing in Real Time
A team of scientists use fluorescently labeled proteins and CRISPR technology to image DNA transcription and chromosomal rearrangements....
OCT 18, 2019
Cell & Molecular Biology
OCT 18, 2019
A Molecular Connection Between Depression and Chronic Pain is IDed
The stress of chronic pain has been known to be associated with depression for many years, and scientists have been studying the basis of that connection....
OCT 18, 2019
Drug Discovery & Development
OCT 18, 2019
Tailor-made Drug for Girl with Rare Genetic Disease
Researchers have used personalized medicine to develop a tailor-made genetic treatment for a girl diagnosed with a rare genetic disease known as Batten dis...
OCT 18, 2019
Cell & Molecular Biology
OCT 18, 2019
Discovery of Cell's Mechanism for Sensing Oxygen Wins Nobel
It may be possible to attack cancer or treat anemia or other diseases by interfering with the cells' ability to sense oxygen....
Loading Comments...